The hypermethylated genes SLC7A11 and CD2AP were primarily associated with better prognosis in cancer, whereas the hypomethylated gene MYL6 was predominantly associated with poor prognosis in PCPG (Supplementary Figure 2C). This evidence concerns the gene MYL6 and cancer.